Next-generation cell and gene therapy

Browse venture capital firms focused on Next-generation cell and gene therapy.

Explore VC firms that invest in Next-generation cell and gene therapy. Filter by country and stage to refine results.

1 of 1000 firms
Filters:
UCB Ventures favicon
UCB Ventures
Belgium, United Kingdom, United States

UCB Ventures is an evergreen strategic corporate venture fund established in 2017. It makes long-term investments in early-stage companies developing novel therapeutic modalities and platforms in areas adjacent to UCB's therapeutic focus. The firm works closely with entrepreneurs to maximize patient value.

Founded 2017
Investment Stages
Seed
Series A
Series B
Markets
Next-generation cell and gene therapy
regenerative medicine
cell and tissue homeostasis
RNA modulation
Oligo-based and synthetic biology therapeutics